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Abstract The gradual accumulation of damage and
dysregulation during the aging of living organisms is
readily quantified. Even so, the aging process is com-
plex – with multiple interacting physiological scales.
Computational models that simulate realistic individ-
ual trajectories of health during aging, and that include
mortality, can significantly advance our understanding
of aging. To do so, they must be systems-level mod-
els that incorporate interactions between measurable
aspects of age-associated changes. To incorporate indi-
vidual variability in the aging process, models must be
stochastic. To be useful they should also be predictive,
and so must be fit or parameterized by data from large
populations of aging individuals. In this perspective, we
outline where we have been, where we are, and where
we hope to go in computational models of aging. Our
focus is on systems-level models, and on their great po-
tential in aging research.
Keywords Computational Model · Stochastic Simu-
lation · Machine Learning · Synthetic Populations
1 Introduction: Challenges of Studying Aging
Computational models are essential to make state-of-
the-art predictions or to understand mechanisms within
complex non-linear, stochastic, and interconnected sys-
tems such as the economy, the weather, or the climate.
In this section we outline how aging organisms are also
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complex, interconnected systems. In particular, we high-
light some challenges of understanding aging – and so
also of modelling aging.
Aging populations exhibit increasing mortality rates.
For humans, the risk of dying increases approximately
exponentially for older ages – the famous Gompertz law
of mortality (Kirkwood, 2015). Before death, individual
health can be assessed in many ways. One such mea-
sure is provided by the Frailty Index (FI) which is the
proportion of “things wrong” from a large selection of
possible age-related deficits of health and function (Mit-
nitski et al., 2001). The FI is robust, flexible, and is
strongly correlated with various outcome measures in-
cluding mortality (Rockwood et al., 2005; Evans et al.,
2014). Alternatively, Biological Age (BA) is an “effec-
tive age” defined in terms of an individual’s health,
often using molecular aspects of health such as epige-
netic methylation (Hannum et al., 2013; Horvath, 2013;
Levine, 2020). Other summary measures of health have
been developed, including allostatic load (McEwen and
Stellar, 1993), and physiological disregulation (Milot
et al., 2014). Different summary measures of health are
not necessarily strongly correlated with each other at
the individual level (Li et al., 2020), though we expect
them all to be associated with future adverse health
outcomes.
As assessed by the FI, the distribution of health
measures broadens with age, corresponding to distinc-
tive individual trajectories of health (Rockwood et al.,
2004). Worsening health over an individual’s life is a
random process, and is described as a stochastic ac-
cumulation of damage. It is thought that this damage
underlies the increased mortality with age that is char-
acterized by Gompertz’s law (Gavrilov and Gavrilova,
2001).
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Remarkably, even relatively simple empirical obser-
vations about aging and mortality are not well under-
stood. Resolving the question of whether Gompertz’s
law applies for extremely old populations or whether
they exhibit a mortality deceleration or plateau remains
challenging due to small data-sets (Gavrilov and Gavrilova,
2019). The ‘mortality-morbidity paradox’ whereby fe-
male populations live longer than male populations, de-
spite male populations apparently having better health,
remains unexplained (Gordon et al., 2017; Kulminski
et al., 2008). The mechanisms behind historically chang-
ing health and mortality within national populations
(Crimmins, 2015; Colchero et al., 2016), or behind dif-
ferences between different socio-economic groups within
a population (Andrew et al., 2012), are even more chal-
lenging to uncover. We have generally been limited to
descriptive or correlative approaches to population-level
questions about aging.
Four broad challenges of studying aging are clear:
how can we affordably and effectively observe health
and mortality across large populations, how can we bet-
ter understand the mechanisms or causes underlying
what we observe, how can we better predict outcomes
at an individual or population level, and, finally, how
can we better intervene to decrease mortality and to
improve health during aging? These challenges are in-
terconnected: better measurement leads to better un-
derstanding, which leads to better prediction, and ulti-
mately to better treatment.
Success in aging research crucially depends on the
broad availability of high-quality data. National stud-
ies, especially those that include longitudinal data on
study participants, such as the CSHA (Canadian Study
of Health and Aging Working Group, 1994), CLSA (Raina
et al., 2009), NHANES (Centers for Disease Control
and Prevention National Center for Health Statistics,
Updated 2014), BLSA (Ferrucci, 2008), ELSA (Step-
toe et al., 2014), and the UK Biobank (Sudlow et al.,
2015), are of increasing importance and utility. Emerg-
ing sources of data include electronic health records
(EHR) (Clegg et al., 2016), molecular ’omics data, and
individual telemetry provided by health monitors or
cellphones.
There are also many scales of health measures to
consider: from molecular and cellular, to tissue, to or-
ganismal. For example, at the molecular scale methyla-
tion clocks have emerged as convenient epigenetic hall-
marks of health and aging (Hannum et al., 2013; Hor-
vath, 2013). Other high-throughput technologies such
as genomics, transcriptomics, proteomics, metabolomics,
and microbiomics provide affordable ways of conduct-
ing aging studies over populations (Livshits et al., 2018;
Lehallier et al., 2019; Ahadi et al., 2020). Conversely,
clinically relevant aspects of health such as activities
of daily living (ADL) and other measures of functional
disability are particularly important to the aging of in-
dividual older adults. Such ‘higher’ levels of function
are dependent on many aspects of ‘lower-level’ biolog-
ical and molecular function in a variety of tissues. Un-
derstanding how different scales of organismal function
interact with each other should help us to effectively
translate advances from one scale to another, and iden-
tify interventions that target the lower-level biologi-
cal function before it manifests as functional disability
(Ferrucci et al., 2018).
Continuing the historical advances in either life ex-
pectancy or healthy-aging will be increasingly challeng-
ing but, naturally, is of great interest to the geroscience
community. Targeted interventions for aging individu-
als will often be in the context of significant comor-
bidities or polypharmacy. Systemic treatments such as
exercise (Fried, 2016; Partridge et al., 2018), caloric re-
striction (Most et al., 2017; Mattson et al., 2017), or
senolytics (Xu et al., 2018), act at cellular or molecular
scales but the desired effects are often at the organis-
mal scale. Understanding interventions includes under-
standing how the effects of interventions propagate be-
tween organismal scales. This will likely depend on the
health-state and age of the individual – as well as the
intervention under consideration. Nevertheless, greater
understanding could help us select, guide, apply, and
improve interventions for individualized treatment.
Animal models of aging have instructive similarities
and differences with respect to human aging (Cohen,
2018). Simple animal models are particularly amenable
to studying the effects of controlled interventions in
the aging process. Efficient automated image analy-
sis is also starting to lead to high-quality longitudinal
studies of model organisms (see e.g. worms (Swierczek
et al., 2011; Zhang et al., 2016), or flies (Seroude et al.,
2002)). Developing insights from frequently-measured
high-dimensional organismal health states within large
model populations will require new suites of analysis
and modelling tools.
Given the complexity of the aging process, how can
theoretical models make use of available and emerging
sources of data in order to improve our understanding
of aging within and between populations or species, to
better predict individual aging outcomes, and to both
understand existing interventions and to develop better
individualized interventions in the aging process?
2 Theoretical approaches to Aging
Conceptual models such as the hallmarks of aging (Lo´pez-
Ot´ın et al., 2013), seven pillars of aging (Kennedy et al.,
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2014), or damage accumulation (Kirkwood, 2005) can
provide powerful frameworks for discussion or interpre-
tation of quantitative results, but they are not typi-
cally quantitative themselves. While they organize how
we think about aging, they do not directly help us to
quantitatively characterize observed data or to make
quantitative predictions.
Statistical models make simplifying assumptions about
how covariates are related to an outcome. These mod-
els can be used to test hypotheses about the differences
between groups or the effects of covariates on an out-
come, or be used to make predictions of individual out-
comes given measured covariates. However, these mod-
els generally include few assumptions specific to mech-
anisms of aging. When assumptions are motivated by
some knowledge of the mechanisms of aging itself, then
the model becomes a theory of aging.
Even summary measures of aging require assump-
tions. For example, the Frailty Index (FI) is simply
the proportion of age-related binary health-deficits that
have been accumulated – but the uniform weighting
of deficits or the selection of which attributes to in-
cluded is driven by qualitative considerations (i.e. as-
sumptions about what is important). Even the use of
binarized (healthy vs not) variables has underlying as-
sumptions and methodology (Stubbings et al., 2020).
Similarly, biological age (BA) estimates are often ob-
tained by regressing age against biological variables –
which assumes a specific predictive model.
The lightest quantitative models are largely descrip-
tive, or phenomenological. An example is Gompertz’s
exponential increase of mortality with age for older
adults (Kirkwood, 2015). This is not an exact model
over any age range, but it is a useful approximation.
Related to that is the Strehler-Mildvan correlation be-
tween the amplitude and exponent of the Gompertz law
(Tarkhov et al., 2017), or the discussion of maximum
human lifespan (Dolgin, 2018). Such phenomenological
models beg explanation of mechanisms, but typically
do not provide or require that explanation themselves.
Furthermore, such simple quantitative models are not
able to describe multiple organismal scales of aging. For
example, they describe mortality but not health. As a
result, they are not typically useful for predicting indi-
vidual health outcomes.
2.1 Dynamical Models of Aging
Dynamical models explicitly simulate individual health
trajectories vs age, i.e. longitudinal data. Because they
generate synthetic individual data, they can serve much
the same role as model organisms – whereby differ-
ences with respect to human aging can be significant
but hopefully are also informative.
Dynamical models can include explicit interpretable
mechanisms. Whereas statistical regression models can
quantify the relationship between aspects of aging, they
do not determine how the relationship arises. With dy-
namical models one can build mechanisms into the model.
Any success of a dynamical model in reproducing real-
world phenomena then suggests the viability of the un-
derlying mechanisms, and allows the modeller to ex-
plore other phenomena that arise from the same mech-
anisms – which allows them to test the model.
A summary of early modelling work is provided in
the review by Yashin et al. (2000). Yashin and col-
leagues also developed the quadratic hazards model (or
stochastic process model, SPM) of aging (Yashin et al.,
2012; Arbeev et al., 2016). It postulates that individual
deviations from age-dependent norms of physiological
measures interact with and exacerbate each other.
The concept of interactions between health mea-
sures can be embodied in a network of interactions,
where nodes (or “vertices”) are the health measures
while the interactions are connections between nodes
(links, or “edges”). Such explicit networks were used
to model mortality, such as the reliability theory of
Gavrilov and Gavrilova (2001) or the network model
of Vural et al. (2014). We developed what we now call
a generic network model (GNM) to also model health
measures such as the FI, and found that we could de-
scribe both population-level aging and mortality with
a simple network of interactions that could be imple-
mented on a computer to generate large synthetic pop-
ulations (Taneja et al., 2016; Farrell et al., 2016, 2018).
Nevertheless, the health attributes (nodes) of our
GNM did not directly correspond to specific observed
health attributes. The reason for that approach was
simplicity: all connected nodes have the same inter-
actions, with simple undirected connections of equal
weight, as illustrated in Figure 1. This enabled us to
capture population-level health and mortality. To be
able to predict detailed individual health states, we
would need to empirically capture many interactions
between observed individual health attributes within a
population.
Reconstructing interactions from observed data is
a daunting prospect. If hundreds of individual health
attributes are measured, then there are tens of thou-
sands of interactions to determine between all possible
pairs of attributes. Nevertheless, initial progress is be-
ing made on smaller-sized problems. Using only cross-
sectional binarized health data, we have developed a
network model that includes specific observed health
attributes (Farrell et al., 2020). To accomplish this,
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Fig. 1 Links (grey lines) between nodes (circles) in a generic
network model (GNM) of aging. Shown are a selection of 112
nodes, out of 104 used in the model. Nodes do not represent
particular observed health variables, but larger circles indi-
cate nodes with more links. The most connected nodes are
coloured orange, and are used in the aggregate health mea-
sure (frailty index, or FI) of the GNM. Note that the links
do not change with age, while the binary health-state of the
nodes does change with age between healthy and unhealthy.
This model, with stochastic damage rates that can be imple-
mented computationally (Taneja et al., 2016; Farrell et al.,
2016, 2018), can generate large synthetic populations that re-
flect observed population-average age-dependent health and
mortality rates.
Fig. 2 Weighted and directed links (arrows) between nodes
(circles) in a weighted network model (WNM) of aging.
Shown are 10 nodes, each of which represents specific ob-
served binary health variables from cross-sectional studies.
Only the more significant links are shown, with weights repre-
sented by the line thickness and arrow size. This model, with
stochastic damage rates that can be implemented computa-
tionally (Farrell et al., 2020), can generate large synthetic
populations that reflect observed high-dimensional health-
states and mortality over the populations used to fit the
model. See Figs. 3 and 4 below. Note that the full model only
has 10 nodes, representing just the observed health-states.
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Fig. 3 Simulated joint distributions of FI at death and death
age from the network model described in Farrell et al. (2020),
and illustrated in Fig. 2, given four individuals with the indi-
cated initial baseline deficits (filled red points indicate their
baseline age and FI). This demonstrates the capability of
simulating populations of synthetic individuals, starting from
different baseline conditions. The two columns show baseline
ages of 65 (A and C) and 85 (B and D), the rows show dif-
ferent baseline FIs of 0.1 (A and B) and 0.3 (C and D), for a
FI with 10 deficits. Note that the maximal observed FI is 1,
reflecting the small number of deficits used in its construction.
the model parameters are distinct for each node and
the network connections between nodes are distinctly
weighted. An illustration of such a “weighted” network
model (WNM) is shown in Figure 2. The new model can
be used to generate individual health trajectories and
mortality from any starting point, as illustrated in Fig-
ures 3 and 4, or to generate large synthetic populations
with observable health states.
While these synthetic populations resemble observed
aging populations, we are not yet able to robustly in-
fer specific interactions between the observed health at-
tributes, and we find that many different networks are
consistent with the observed data. We are currently de-
veloping a more generalized approach, using continuous-
valued longitudinal datasets, to make individual predic-
tions of aging trajectories and infer a robust network of
interactions on the level of blood biomarkers and func-
tional disabilities.
3 Computational models
All but the simplest dynamical models need to be im-
plemented computationally. Computational models al-
low us to simulate and explore the quantitative conse-
quences of various hypotheses. That is, since compu-
tational models require well-defined algorithms, they
force us to make our assumptions explicitly. By varying
those assumptions we can explore their consequences.
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Fig. 4 Distribution of sampled FI trajectories vs age from
the network model described in Farrell et al. (2020) and il-
lustrated in Fig. 2, given given four individuals with the indi-
cated initial baseline deficits. Trajectories are shown for sam-
ples with the median predicted death age, for the same in-
dividuals shown in Fig. 3. The purple shading indicates the
percent of trajectories passing through each local region. The
red circles indicates the baseline age and FI from which the
simulation is started. The two columns show baseline ages
of 65 (A and C) and 85 (B and D), the rows show different
baseline FIs of 0.1 (A and B) and 0.3 (C and D), for a FI
with 10 deficits.
This can clarify and illuminate possible mechanisms of
aging.
Computational dynamical models can generate large
synthetic populations of individuals with complete health
trajectories and mortality. Such “perfect” data facili-
tates the systematic development of data analysis tools,
including determining their statistical power for finite
populations with missing data. More fundamentally,
computational models also allow for a close examina-
tion of mechanisms at the population level: how does
changing an assumption or a model parameter change
the resulting health and mortality statistics of the pop-
ulation? The mechanisms behind the observed statistics
of aging populations is a fundamental question of ag-
ing that can be answered, at least within the context of
these model populations.
The other side of the coin is that a significant dis-
advantage of modelling is that every assumption needs
to be explicitly built into the mathematical framework
of the model, and every parameter needs to be deter-
mined. This is in contrast to observational studies of
human or organismal populations, in which the assump-
tions and effective parameters are all implicitly included
by biology. As a result, while natural observation natu-
rally includes everything (including the “kitchen sink”),
a modelling approach typically only builds a minimal
framework to address the mechanisms under consider-
ation. This constructive flavour of modelling lends it-
self to inter-organismal comparisons, since we can ask
whether parameter tuning alone can explain differences
between organisms or whether the structure of the ag-
ing model needs also to be changed. Similar compar-
isons can be made between any distinct subpopulations
of any one organism, including medically treated vs un-
treated populations or genetically distinct populations.
Structural changes should not be needed to accom-
modate small differences between populations. Conversely,
structural differences between models will lead to dis-
tinctive effects that can be observed and therefore tested
in observations of natural populations. However, testa-
bility will be challenging for mechanisms that are not
already well characterized. For example, we expect that
the effects of genetically heterogeneous human popula-
tions that will eventually be important to characterize
and include in models, but it will be hard to separate
those effects from the intrinsic variability of the aging
process. Nevertheless, a successful modelling framework
should allow us to identify the statistical signatures of
proposed mechanisms – which will facilitate subsequent
testing.
To paraphrase Box (1976), all models are at least
partially wrong but some can nevertheless be useful.
However, rather than just trying to be mostly right
or fairly useful, models should be improvable. This re-
quires cycles of testing, development, and application to
continually confront models with observable data. The
benefit of this approach is that we can continually ad-
just our implicit or explicit assumptions to better and
more usefully reflect emerging datasets.
3.1 Generalizability
Given the complexity of any organism, together with
the complexity of the aging process, we can anticipate
an enormous number of parameters required to tune
complex models to fit a population. This tuning (also
variously called fitting, learning, parameterization, or
regression – depending on the context) is necessary if
we want to do more than explore the qualitative conse-
quences of a small set of model assumptions. Fitting the
model to the data is necessary to make predictions for
individuals, to compare populations, and to generate
realistic synthetic populations.
We can distinguish between effective and fundamen-
tal parameters. Fundamental parameters would be model
independent, can be measured or derived with a variety
of techniques, and are unchanged in different contexts.
Effective parameters (of effective theories (Transtrum
et al., 2015)), on the other hand, cannot be precisely
replicated in different contexts and cannot be derived
from any fundamental assumptions. We expect that al-
most all parameters of models of aging will be effec-
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tive parameters, i.e. they will be at least somewhat
dependent on the choice of model. Nevertheless, ef-
fective parameters should not be treated as arbitrary
tuning-knobs of a model. More useful parameters will
change less between studies, will be more interpretable,
and will lead to better model predictions. Determin-
ing good model structure that facilitates useful param-
eterizations is an iterative process that is one goal of
successful modelling.
The technical details of fitting a model are well un-
derstood. Simple models can be hand-tuned to agree
with population-level measures; however such simple
models will not provide the best individual-level predic-
tions. More sophisticated models can be fit with maxi-
mum likelihood, or other objective or “loss” functions,
to obtain a model that best fits the available data.
Bayesian approaches are also possible, where posterior
distributions of parameters are obtained, rather than
single point estimates.
An ideal data set would have a large homogeneous
population, with complete, detailed health information
that is longitudinally sampled frequently over individ-
ual lifetimes with uncensored mortality data. A com-
putational model should be able to capture the impor-
tant behavior exhibited in such data, so that it can
then be used for individual predictions. Better compu-
tational models would provide better predictions. Are
there other ways of distinguishing between such mod-
els? After all, even the best human data sets have small
heterogeneous populations compared to national or global
scales, with significant amounts of missing and censored
data, and with irregular and infrequent longitudinal
sampling with respect to the daily or weekly variability
of our individual health status.
The answer hinges on how generalizable the model
is to different data sets. If the model fit to one dataset
poorly generalizes to other datasets – then the model
has “failed”. It has failed in a useful way (Box, 1976)
if we can expand the model in an interpretable way
to accommodate both datasets. It has failed in a disap-
pointing way if we cannot, and if we cannot understand
why not.
It will be exciting to ask whether we can also gener-
alize models to different applications. For example, con-
sider interventions in the health of individual organisms
due to drugs, surgery, treatment, lifestyle, accidents,
illness, or (in the case of model organisms) experimen-
tal manipulation. Can a model predict the outcomes
of such interventions? Better predictions could be used
to both improve individual treatment plans and man-
age the health-care of increasingly greying populations
(Harper, 2014).
Nevertheless, we might expect that any predictive
model that is optimally tuned to predicting specific
mortality or health outcomes will not be easily gen-
eralized to predict other outcomes. While part of this
limitation naturally arises from the data used to train
the model, some of this limitation will also come from
the model structure itself, since computational models
will not be able to capture effects that are not allowed
for in the model structure. Since the model structure
itself may limit generalizability, some model structures
(‘types of models’) will be better than others for this
purpose.
3.2 Sloppiness, overfitting, and bias
Any computational model of aging will also be at risk of
underdetermined parameters, overfitting, and bias from
the data sets used in training.
Underdetermined parameters are parameters of the
model that are not well constrained by the available
data, but are nevertheless important for model func-
tioning. A loose analogy may be handedness of am-
bidextrous people: while a hand might be used for hand-
writing, which hand is much less constrained. Slop-
piness results in strong correlations between param-
eters that each range widely in magnitude. As a re-
sult, when considered individually these poorly con-
strained or “sloppy” parameters have large uncertain-
ties (Gutenkunst et al., 2007; Transtrum et al., 2015) –
even when the model can still make robust predictions.
This may not be a problem for models with effective pa-
rameters that aren’t directly interpreted, since the ro-
bustness of model prediction is not necessarily affected
by sloppy parameters. However, if direct interpretation
of parameters is desired, sharpening sloppy parameters
involves either acquiring new data that allows more pre-
cise parameter determination or adding assumptions to
the model. Large clean datasets generated by compu-
tational models can be used to determine the types of
observational data that would be needed to sharpen
parameters.
Overfitting is another generic problem with complex
models with many parameters. Here, parameter values
are fine-tuned to extract small improvements in fitting
to the training data at the expense of good performance
with new data. Overfitting is assessed by using dedi-
cated training data and separate but comparable test
data to assess model performance. Since fitting typi-
cally occurs through an iterative computational algo-
rithm, overfitting can be minimized by model selection
or stopping the fitting process when model performance
on a held-out portion of the training data (the valida-
tion or development data) begins to decline.
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When test data is not comparable to training data
then poor model performance can reflect poor general-
izability due to limitations of the training data rather
than overfitting. Some problem of generalizability arises
in most training datasets, because they have biases in
demographics (age distribution, sex, race), health-state
of enrolled participants, medical treatment during the
course of the study, or in any other possible category
within the dataset.
While there are many biases possible in data analy-
sis, modelling bias can also arise due to the structure of
model not being able to account for all aspects of the
data. For example, survivor bias (Murphy et al., 2011)
can be troublesome for models that do not capture mor-
tality properly. When measured covariates have associa-
tions with mortality, the drop-out of individuals during
the study due to mortality can bias the results. Models
must account for survival effects with joint longitudinal-
survival models (Hickey et al., 2016) that model health
and survival together – otherwise modelling efforts can
erroneously try to accommodate survival effects within
the disease progression itself.
4 Machine Learning
Machine Learning (ML) is a loosely-defined term for a
collection of data-based models that are typically fit or
“trained” with large high-dimensional data sets. Typi-
cal goals of ML approaches are classification (the most
common application (Domingos, 2012), though not our
focus here), regression, and generating synthetic sam-
ples with the same properties as the observed data.
Neural networks are often used in more sophisti-
cated ML models (Goodfellow et al., 2016), as in deep
learning (LeCun et al., 2015). Neural networks consist
of layers of artificial neurons that each have many lin-
early combined input connections from previous layers,
and many output connections to subsequent layers. All
connection parameters for every neuron are trainable.
Non-linear transformations in each neuron allow multi-
ple layers (i.e. “deep” networks) to represent functions
of arbitrary complexity (Leshno et al., 1993; Raghu
et al., 2017).
Powerful neural networks have enormous numbers
of parameters that must be trained for the network
to represent the desired function. Neural networks are
designed so that this training is computationally effi-
cient and parallelizable. However, overfitting is a con-
cern with so many parameters, and it is managed by
careful use of regularization, which imposes restrictions
on the parameters learned by the model. Test data,
not used in training, is an important part of evaluating
model performance and behavior.
Any unknown component of a model of aging can
therefore be learned with a neural network, given suffi-
cient training data. However, the researcher still needs
to develop the overall structure of the model (i.e. how
all the pieces “glue” together), choose appropriate neu-
ral network architectures, and manage the algorithms
(and their “hyper”-parameters) that train the model
while avoiding overfitting.
While initial exposure to ML is not for the faint
of heart, new ML tools are easily learned and used af-
ter some expertise is gained. It is more challenging to
achieve the goals of generalizability, where models per-
form well on data that is unlike the training set, and
interpretability, where the mechanisms of the model
can be understood and related to mechanisms in other
model systems. Both of these goals are difficult because
the flexibility of deep neural networks together with
the efficient training algorithms requires huge numbers
of parameters (limiting interpretability) and leads to
strong bias outside the regime of training data (limiting
generalizability). While large natural data sets can help
with generalizability, interpretability has been more dif-
ficult to achieve (Rudin, 2019).
4.1 ML approaches in ageing research
Several ML models have been developed specifically for
aging. Pierson et al. (Pierson et al., 2019) developed a
model that infers “rates of aging” for individuals that
correlate with risk factors of aging, and that can be
used to forecast future health. Avchaciov et al. (2020)
developed a model that describes the aging of mice with
an inferred “dynamical frailty index”, which correlates
with both mortality and treatment effects.
Similarly, machine learning has already had success
in the estimation of biological age (Hannum et al., 2013;
Horvath, 2013; Levine et al., 2018; Lu et al., 2019).
With these models, millions of biological variables (e.g.
DNA methylation) are reduced to a single estimate of
biological age, which is found to be predictive of other
health outcomes and mortality. As more data becomes
available, sophisticated techniques that can be used for
assessing biological age are emerging (Putin et al., 2016;
Pyrkov et al., 2018; Schultz et al., 2019; Zhavoronkov
and Mamoshina, 2019).
Nevertheless, models of biological age are not dy-
namical models – they cannot simulate the future health
trajectories of individuals, but only summarize and in-
terpret the current health state. Furthermore, since re-
ducing health to a single variable cannot capture multi-
dimensional aspects of health, we believe that develop-
ing dynamical models that address longitudinal trajec-
tories across multiple health dimensions is a particu-
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larly promising direction for machine learning in aging
research.
To forecast multi-dimensional health trajectories,
existing machine learning approaches for modelling dis-
ease progression could be adapted to model aging pro-
gression. While many of these do not model mortality
(Schulam and Suchi, 2015; Alaa and van der Schaar,
2018; Fisher et al., 2019; Walsh et al., 2020), joint longit-
udinal-survival models could be adapted (Lim and van der
Schaar, 2018). A stochastic process model of aging has
already been developed that models both health trajec-
tories and mortality (Yashin et al., 2007; Arbeev et al.,
2011; Yashin et al., 2012; Arbeev et al., 2014), but it
has not yet been applied to high-dimensional datasets.
Given efficient algorithms for parameter determina-
tion (learning) together with arbitrary functional de-
pendence (deep learning), we see great promise for ML
approaches in the study of aging. Natural applications
are filling in missing data, identifying natural subpopu-
lations or categories of aging organisms, incorporating
multiple heterogeneous data sources, and modelling the
aging process itself as a stochastic dynamical process.
5 Challenges for aging models
In the introduction, we listed four challenges of study-
ing aging: how to better observe health in aging pop-
ulations, how better understand the mechanisms be-
hind what we observe, how to better predict individual
health, and how to better intervene in the aging pro-
cess. In this section we revisit those challenges in the
context of computational models of the aging process.
5.1 E-health and self-reported data
Focused population surveys are expensive. Large scale
studies such as CSHA (Canadian Study of Health and
Aging Working Group, 1994) or NHANES (Centers for
Disease Control and Prevention National Center for
Health Statistics, Updated 2014) are limited to popu-
lations on the order of 10000 individuals. Even the im-
pressive UK Biobank has less than one million individ-
uals (Sudlow et al., 2015). In contrast, the use of elec-
tronic health records (EHR) (Clegg et al., 2016) could
eventually reach large fractions of national populations
with lifetime longitudinal data. EHR is therefore an at-
tractive source of data on the aging process. Similarly,
individual health tracking through e.g. smart watches,
or through self-reporting apps, could also reach large
fractions of national populations. These developments
will provide natural datasets with large populations
that have lifetime longitudinal information, perhaps quite
finely-grained in time.
However, significant biases are found in EHR data
(Vassy et al., 2018) and also in self-reported health data
(Zajacova and Dowd, 2011; Gunasekara et al., 2012).
While it would be difficult to explicitly account for these
biases in order to reconcile EHR and self-reported data
with corresponding national prospective studies from
similar populations, an easier challenge will be to di-
rectly exploit this data for individual-level health mod-
els and predictions (Jylha¨, 2009).
5.2 Defining and comparing populations
Some u¨ber-model of aging might explicitly capture each
aspect of individual variability, including a life-history
of diet, lifestyle, injury, medication, and health-care.
More realistically, most variability will first need to be
captured implicitly within aging models through pa-
rameterization or model structure – tuned for differ-
ent natural subpopulations. Race (Williams, 2005), sex
(Gordon et al., 2017), socioeconomic position (Knese-
beck et al., 2007), social vulnerability (Wallace et al.,
2015), access to health-care (Santana, 2000) or pensions
(Aguila et al., 2018), rural/urban (Yu et al., 2012), and
nationality, are all categories that have been studied by
aging researchers. Chronic disease, genetic disorders,
and certain patterns of multimorbidity or polyphar-
macy could also serve as natural categories. A chal-
lenge will then be to reduce the significance of these
natural categories for individuals by making the more
of the implicit differences between the populations ex-
plicit – allowing for better individualized study of ag-
ing and treatment. To be able to achieve this requires
good data coverage across many subpopulations, but
also good models that can characterize and model the
differences.
We would expect that different species, i.e. animal
models of aging, would require some structural differ-
ences to model accurately. Part of this is that differ-
ent data is available for them. For example, cognitive
data is less available in animal models, and health-care
is often irrelevant. Nevertheless, modelling animal ag-
ing and determining what those differences are will help
us understand how aging naturally progresses, and how
health-care changes the aging process for humans. Mod-
elling could help us to determine how much human
interventions mitigate and/or exacerbate the intrinsic
variability of human populations to produce the ob-
served variability of individual aging.
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5.3 Multiple scales
Different physiological scales present exciting opportu-
nities in aging research. For example, molecular data
is appealing because it can be high throughput and
low-bias. Nevertheless, outcomes at higher (functional)
scales are typically of greater individual interest. One
challenge is to identify interactions between scales, from
molecular to behavioral, and to incorporate them in ag-
ing models (Ferrucci et al., 2018; Mitnitski and Rock-
wood, 2019; Kuo et al., 2020). Reliably bridging the
scales, particular in light of patchwork individual data
(over scale, over time, and over individual measures),
is an important challenge. Understanding how different
scales work is the essence of understanding the aging
process. How does damage propagate from the molec-
ular to activities of daily living? Conversely, how do
interventions of lifestyle or injuries propagate towards
the molecular?
5.4 Longitudinal studies
Large-scale longitudinal data collection provides an op-
portunity for aging models to employ these data to bet-
ter capture the aging process of individuals, including
individual variability. Natural questions include how
much is gained by more frequent measurements, how to
best handle variables observed at irregular time inter-
vals and with varying degrees of missing observations,
how to model mixtures of qualitative and quantitative
measurements or of self-reported and molecular mea-
sures, and how to include individual health histories in
individual health predictions. Computational models of
aging are well placed to make use of longitudinal data.
The challenge is to do so; and to do so with a compu-
tationally efficient approach given the vast amount of
data potentially available.
5.5 Predictions
Although individual predictions of health trajectories
and mortality are natural goals for computational mod-
els of aging, a challenge is how to evaluate and judge
the quality of the predictions. Evaluation is straight-
forward retrospectively, by using separate training and
test populations with either cross-sectional or longitu-
dinal data with linked mortality. The determination of
what quality of predictions are possible with what sort
of data for individuals of a given age and health status
are important questions to answer.
5.6 Medicine, illness, and interventions
Being able to predict the individual results of medi-
cal interventions (including medication), of illness or
injury, or of life-style interventions such as exercise is
crucially important. Most individuals experience many
such interventions over their lifetime, so these are im-
plicitly and approximately included in models of na-
tional aging populations. Indeed, we assume that such
interventions are the origin of many national differences
or differences within a national population over history.
A grand challenge will be to make these interven-
tions explicit, particularly within models of individual
health during aging. If successful, such explicit models
will allow better individual prediction, better identifi-
cation of intrinsic variability, and the ability to tailor
or individualize interventions to better reflect individ-
ual priorities. To do this well we may need to include
earlier data across individual life courses for large pop-
ulations, including electronic health records and longi-
tudinal data.
6 Looking ahead
Early modelling has been restricted to simple theo-
retical or statistical explorations of the aging process,
through damage accumulation or regression models. Though
this approach has limited ability to predict individual
health, it has advanced our conceptual understanding
of how aging could work.
More recently, various models have started to ad-
dress observational data that includes the detailed health
and mortality of large numbers of individuals, which
we call “networked” models since they capture inter-
actions between different aspects of individual health.
Our work in this area has included explicit complex net-
works (Taneja et al., 2016; Farrell et al., 2016, 2018),
but the networks can also be theoretical (Yashin et al.,
2012; Arbeev et al., 2016), correlational (Hidalgo et al.,
2009; Roque et al., 2011; Garc´ıa-Pen˜a et al., 2019), or
implicit in the approach. Few models have addressed
both individual health and mortality, though these are
now starting to emerge (Farrell et al., 2020).
Once multiple stochastic models with both health
and mortality are developed, then the natural scientific
selection of “better” models can proceed by confronting
their simulated results with observed data. Natural mea-
sures of goodness of models include predictive quality,
generalizability across different population demograph-
ics (including age and health, but also sex and chronic
conditions), interpretability, and the ability to effec-
tively and efficiently train with big heterogeneous data
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sets. The ability to efficiently and effectively predict fu-
ture individual health trajectories will be revolutionary,
particularly if models include the effects of injury and
disease, or the benefit of various medical and pharma-
cological interventions.
While observational data sets will only increase both
in the number of individuals, in the number of physio-
logical aspects of health that are reported, and in the
frequency of longitudinal measurements, the amount of
easy-available data available to train, test, and com-
pare modelling approaches is still limited. Public “chal-
lenge” datasets could provide realistically imperfect but
extensive longitudinal health data together with mor-
tality statistics to allow for comparison between and
improvement of modelling approaches. Providing raw
data together with cleaned data is important, since im-
provements in data-cleaning (Van den Broeck et al.,
2005) can also lead to model improvement – and compu-
tational pipelines of data-cleaning will be increasingly
necessary for large population studies.
We will never achieve a “death-clock” where we can
precisely predict an individual’s death, nor a health-
calendar of precisely how their health will change as
they age. Nevertheless, we may be able to classify and
identify useful aging phenotypes, to obtain good pre-
dictions of individual health-trajectories and mortality,
and to identify the most useful health interventions for
a given individual. Because computational models can
capture the effects of many interacting aspects of hu-
man physiology, they are promising tools to use to help
to address these questions.
How computational models can and will be used
will depend on how successful they become. We believe
that they will lead to a deeper understanding of how
aging works, both for human aging and for model or-
ganisms. They could also help to control for the effects
of different populations, to improve national or regional
comparisons of the determinants of health. We also ex-
pect that models will be able to capture the effects of
various health interventions at the individual level. If
models become sufficiently good, they would be able
to help individuals to develop and adapt their personal
health plans. We are hopeful.
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